Open access · CC-BY
via OpenAlex
Disruption of lysosomal proteolysis in astrocytes facilitates midbrain organoid proteostasis failure in an early-onset Parkinson’s disease model
Gustavo Morrone Parfitt, Elena Coccia, Camille Goldman, Kristen R. Whitney, Ricardo Reyes, Lily Sarrafha, Ki Hong Nam, Soha Sohail, Drew R. Jones, John F. Crary, Alban Ordureau, Joel Blanchard, Tim Ahfeldt
Nature Communications · 2024 · ▲ 70 citations
Abstract
Accumulation of advanced glycation end products (AGEs) on biopolymers accompanies cellular aging and drives poorly understood disease processes. Here, we studied how AGEs contribute to development of early onset Parkinson's Disease (PD) caused by loss-of-function of DJ1, a protein deglycase. In induced pluripotent stem cell (iPSC)-derived midbrain organoid models deficient for DJ1 activity, we find that lysosomal proteolysis is impaired, causing AGEs to accumulate, α-synuclein (α-syn) phosphorylation to increase, and proteins to aggregate. We demonstrated these processes are at least partly driven by astrocytes, as DJ1 loss reduces their capacity to provide metabolic support and triggers acquisition of a pro-inflammatory phenotype. Consistently, in co-cultures, we find that DJ1-expressing astrocytes are able to reverse the proteolysis deficits of DJ1 knockout midbrain neurons. In conclusion, astrocytes' capacity to clear toxic damaged proteins is critical to preserve neuronal function and their dysfunction contributes to the neurodegeneration observed in a DJ1 loss-of-function PD model.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/s41467-024-44732-2
- Canonical
- link ↗
- Fetched
- 2026-10-27 MST
Cite this
APA
Parfitt, G.M., Coccia, E., Goldman, C., Whitney, K.R., Reyes, R., Sarrafha, L., Nam, K.H., Sohail, S., Jones, D.R., Crary, J.F., Ordureau, A., Blanchard, J., & Ahfeldt, T. (2024). Disruption of lysosomal proteolysis in astrocytes facilitates midbrain organoid proteostasis failure in an early-onset Parkinson’s disease model. <em>Nature Communications</em>. https://doi.org/10.1038/s41467-024-44732-2
Vancouver
Parfitt GM, Coccia E, Goldman C, Whitney KR, Reyes R, Sarrafha L, et al. Disruption of lysosomal proteolysis in astrocytes facilitates midbrain organoid proteostasis failure in an early-onset Parkinson’s disease model. Nature Communications. 2024. doi:10.1038/s41467-024-44732-2.
BibTeX
@article{gustavo2024Disrup,
title = {Disruption of lysosomal proteolysis in astrocytes facilitates midbrain organoid proteostasis failure in an early-onset Parkinson’s disease model},
author = {Gustavo Morrone Parfitt and Elena Coccia and Camille Goldman and Kristen R. Whitney and Ricardo Reyes and Lily Sarrafha and Ki Hong Nam and Soha Sohail and Drew R. Jones and John F. Crary and Alban Ordureau and Joel Blanchard and Tim Ahfeldt},
journal = {Nature Communications},
year = {2024},
doi = {10.1038/s41467-024-44732-2},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Ageing Research Reviews 2014
Open access · CC-BY
Ageing and Parkinson's disease: Why is advancing age the biggest risk factor?
Molecular Brain Research 2004
Preprint · OA
Metallothionein-mediated neuroprotection in genetically engineered mouse models of Parkinson's disease
Antioxidants 2025
Open access · CC-BY
Oxidative Stress, Advanced Glycation End Products (AGEs), and Neurodegeneration in Alzheimer’s Disease: A Metabolic Perspective
Biology of the Cell 2019
Preprint · CC-BY
Targeting of the unfolded protein response (UPR) as therapy for Parkinson's disease
Brain 2005
Open access · OA
α-Synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease
Molecular Neurobiology 2023
Preprint · OA